RxDoctor Payments Data

Kaila Compton

Psychiatry · San Francisco, CANPI 1073771598

Payments from drug & device makers

No general payments reported

No drug or device maker reported general payments to this provider for 2019–2025. That is a common and unremarkable result.

How this compares

$0 in reported general payments places this provider in the 10th percentile of 4,954 psychiatry providers in California.

See all psychiatry providers in California

Medicare billing

Part B allowed, 2024
$657,741
Medicare patients
72
Services billed
791

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
SpravatoEsketamine Hcl12$14,203
Bupropion XlBupropion Hcl41$1,151
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine20$495
Venlafaxine Hcl ErVenlafaxine Hcl19$439
Lamotrigine24$359
Desvenlafaxine Succinate ErDesvenlafaxine Succinate12$238
Lorazepam19$192
Sertraline Hcl22$139
Mirtazapine15$133

Paid to pharmacies, not to this prescriber.

Other psychiatry in San Francisco

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →